Overview

• The wearable integrates inflammation, pH and temperature sensors on a patented high-resistivity silicon platform to continuously track key wound-healing indicators.
• Bluetooth connectivity enables remote, real-time assessment without removing dressings, reducing contamination risks and potential delays in intervention.
• Reusable biocompatible components fit existing manufacturing workflows and could cut per-unit costs to under $5 when produced at scale.
• Laboratory simulations confirmed the device conforms to curved surfaces like human skin while accurately detecting shifts in biomarker levels.
• RMIT researchers are now courting industry partners to advance the proof-of-concept device into clinical validation and scalable production.